JOPIC
Journal of Pulmonology and Intensive Care

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine.

eISSN: 2980-0803
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
Preoperative spontaneous regression of type B2 thymoma in a patient with myasthenia gravis
Abstract
Thymoma is the most common tumor of the anterior mediastinum. Spontaneous regression of thymoma is extremely rare. A 34-year-old female patient without any known disease, admitted by a myasthenic crisis, had a mass of 76 x 53 x 88 mm on thorax computed tomography (CT). The patient received intravenous immunoglobulin (IVIg) treatment for 5 days, pyridostigmine 60 mg/8 hours and prednisone 30 mg/day for the treatment of myasthenic crisis. Thorax CT on the 18th day showed that the mediastinal mass regressed to 63 x 30 x 63 mm. Histopathological analysis after extended thymectomy revealed the diagnosis of type B2 thymoma.

Keywords : Thymoma, neoplasm regression, spontaneous, myasthenia gravis

Download Article


1. Moran CA, Suster S. Thymoma with prominent cystic and hemorrhagicchanges and areas of necrosis and infarction: a clinicopathologic study of25 cases. Am J Surg Pathol. 2001;25(8):1086-1090. doi:10.1097/00000478-200108000-00015
2. Evoli A, Minicuci GM, Vitaliani R, et al. Paraneoplastic diseases associatedwith thymoma. J Neurol. 2007;254(6):756-762. doi:10.1007/s00415-006-0429-z
3. Wolfe GI, Kaminski HJ, Aban IB, et al. Randomized trial of thymectomy inmyasthenia gravis. N Engl J Med. 2016;375(6):511-522. doi:10.1056/NEJMoa1602489
4. Barth D, Nabavi Nouri M, Ng E, Nwe P, Bril V. Comparison of IVIg andplex in patients with myasthenia gravis. Neurology. 2011;76(23):2017-2023.doi:10.1212/WNL.0b013e31821e5505
5. Stewart BW. Mechanisms of apoptosis: integration of genetic, biochemical,and cellular indicators. J Natl Cancer Inst. 1994;86(17):1286-1296.doi:10.1093/jnci/ 86.17.1286
6. Kobayashi Y, Fujii Y, Yano M, et al. Preoperative steroid pulse therapy forinvasive thymoma: clinical experience and mechanism of action. Cancer.2006; 106(9):1901-1907. doi:10.1002/cncr.21875
7. Barratt S, Puthucheary ZA, Plummeridge M. Complete regression of athymoma to glucocorticoids, commenced for palliation of symptoms. Eur JCardiothorac Surg. 2007;31(6):1142-1143. doi:10.1016/j.ejcts.2007.02.032
8. Murie-Fernández M, Gurpide A, de la Cruz S, de Castro P. Total remissionof thymus carcinoma after treatment with intravenous immunoglobulin. ClinTransl Oncol. 2006;8(9):697-699. doi:10.1007/s12094-006-0043-7
9. Phillips MCL, Murtagh DKJ, Sinha SK, Moon BG. Managing metastatic thymomawith metabolic and medical therapy: a case report. Front Oncol. 2020;10:578.Published 2020 May 5. doi:10.3389/fonc.2020.00578
10. Kikuchi N, Yanagawa M, Yoshida Y, et al. Spontaneous regression oftype b3 thymoma with mesothelial cyst: a case report. J Thorac Imaging.2020;35(6):W123-W126. doi:10.1097/RTI.0000000000000550
11. Moran CA, Suster S. “Ancient” (sclerosing) thymomas: a clinicopathologic studyof 10 cases. Am J Clin Pathol. 2004;121(6):867-871. doi:10.1309/E4JB-3EBC-D3R0-8NHG
Article available in :
Volume 1, Issue 3, 2023
Page : 73-75
https://doi.org/10.51271/JOPIC-0017
Article Information
Received : 27 Haz 2023
Accepted : 28 Tem 2023
Published : 29 Ağu 2023
Corresponding Author :

İsmail Tombul:

[email protected]
Citation : Tombul İ, Demiröz ŞM, Şimşek B, et al. Preoperative spontaneous regression of type B2 thymoma in a patient with myasthenia gravis. J Pulmonol Intens Care. 2023;1(3):73-75.

Read: 239
Download : 859
Cited: 0
_Footer